Annual Retained Earnings
-$282.51 M
-$28.51 M-11.22%
31 December 2023
Summary:
Cytosorbents annual retained earnings is currently -$282.51 million, with the most recent change of -$28.51 million (-11.22%) on 31 December 2023. During the last 3 years, it has fallen by -$85.88 million (-43.68%). CTSO annual retained earnings is now -318.98% below its all-time high of -$67.43 million, reached on 31 December 2006.CTSO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$295.34 M
-$2.33 M-0.80%
30 September 2024
Summary:
Cytosorbents quarterly retained earnings is currently -$295.34 million, with the most recent change of -$2.33 million (-0.80%) on 30 September 2024. Over the past year, it has dropped by -$18.67 million (-6.75%). CTSO quarterly retained earnings is now -164435.04% below its all-time high of -$179.50 thousand, reached on 31 August 2005.CTSO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTSO Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.2% | -6.8% |
| 3 y3 years | -43.7% | -39.4% |
| 5 y5 years | -66.7% | -59.8% |
CTSO Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -43.7% | at low | -39.4% | at low |
| 5 y | 5 years | -66.7% | at low | -59.8% | at low |
| alltime | all time | -319.0% | at low | <-9999.0% | at low |
Cytosorbents Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$295.34 M(+0.8%) |
| June 2024 | - | -$293.01 M(+1.4%) |
| Mar 2024 | - | -$288.86 M(+2.3%) |
| Dec 2023 | -$282.51 M(+11.2%) | -$282.51 M(+2.1%) |
| Sept 2023 | - | -$276.67 M(+3.4%) |
| June 2023 | - | -$267.48 M(+2.4%) |
| Mar 2023 | - | -$261.32 M(+2.9%) |
| Dec 2022 | -$254.00 M(+14.8%) | -$254.00 M(+0.3%) |
| Sept 2022 | - | -$253.23 M(+5.1%) |
| June 2022 | - | -$241.03 M(+4.7%) |
| Mar 2022 | - | -$230.15 M(+4.1%) |
| Dec 2021 | -$221.19 M(+12.5%) | -$221.19 M(+4.4%) |
| Sept 2021 | - | -$211.88 M(+3.1%) |
| June 2021 | - | -$205.47 M(+2.3%) |
| Mar 2021 | - | -$200.79 M(+2.1%) |
| Dec 2020 | -$196.63 M(+4.2%) | -$196.63 M(+0.3%) |
| Sept 2020 | - | -$195.95 M(+0.4%) |
| June 2020 | - | -$195.11 M(+1.5%) |
| Mar 2020 | - | -$192.24 M(+1.8%) |
| Dec 2019 | -$188.79 M(+11.4%) | -$188.79 M(+2.1%) |
| Sept 2019 | - | -$184.84 M(+3.9%) |
| June 2019 | - | -$177.96 M(+2.0%) |
| Mar 2019 | - | -$174.41 M(+2.9%) |
| Dec 2018 | -$169.52 M(+11.3%) | -$169.52 M(+3.3%) |
| Sept 2018 | - | -$164.12 M(+1.9%) |
| June 2018 | - | -$161.12 M(+3.7%) |
| Mar 2018 | - | -$155.29 M(+2.0%) |
| Dec 2017 | -$152.31 M(+6.1%) | -$152.31 M(+2.1%) |
| Sept 2017 | - | -$149.17 M(+1.5%) |
| June 2017 | - | -$146.96 M(+0.8%) |
| Mar 2017 | - | -$145.84 M(+1.6%) |
| Dec 2016 | -$143.52 M(+8.3%) | -$143.52 M(+2.5%) |
| Sept 2016 | - | -$140.05 M(+2.0%) |
| June 2016 | - | -$137.37 M(+2.2%) |
| Mar 2016 | - | -$134.36 M(+1.4%) |
| Dec 2015 | -$132.53 M | -$132.53 M(+1.5%) |
| Sept 2015 | - | -$130.52 M(+2.2%) |
| June 2015 | - | -$127.68 M(-1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | -$129.11 M(+3.8%) |
| Dec 2014 | -$124.39 M(+17.6%) | -$124.39 M(+9.2%) |
| Sept 2014 | - | -$113.90 M(+2.5%) |
| June 2014 | - | -$111.12 M(+3.0%) |
| Mar 2014 | - | -$107.90 M(+2.0%) |
| Dec 2013 | -$105.81 M(+7.2%) | -$105.81 M(+1.3%) |
| Sept 2013 | - | -$104.47 M(+1.4%) |
| June 2013 | - | -$102.98 M(+2.0%) |
| Mar 2013 | - | -$100.95 M(+2.2%) |
| Dec 2012 | -$98.73 M(+6.7%) | -$98.73 M(+1.2%) |
| Sept 2012 | - | -$97.55 M(+1.3%) |
| June 2012 | - | -$96.27 M(+1.7%) |
| Mar 2012 | - | -$94.65 M(+2.3%) |
| Dec 2011 | -$92.56 M(+10.2%) | -$92.56 M(+2.1%) |
| Sept 2011 | - | -$90.63 M(+2.8%) |
| June 2011 | - | -$88.16 M(+2.6%) |
| Mar 2011 | - | -$85.95 M(+2.3%) |
| Dec 2010 | -$83.99 M(+6.4%) | -$83.99 M(+1.3%) |
| Sept 2010 | - | -$82.93 M(+1.5%) |
| June 2010 | - | -$81.74 M(+1.4%) |
| Mar 2010 | - | -$80.65 M(+2.2%) |
| Dec 2009 | -$78.90 M(+4.6%) | -$78.90 M(+0.6%) |
| Sept 2009 | - | -$78.43 M(+1.3%) |
| June 2009 | - | -$77.41 M(+1.3%) |
| Mar 2009 | - | -$76.39 M(+1.2%) |
| Dec 2008 | -$75.46 M(+5.5%) | -$75.46 M(+1.1%) |
| Sept 2008 | - | -$74.64 M(+1.4%) |
| June 2008 | - | -$73.62 M(+1.7%) |
| Mar 2008 | - | -$72.38 M(+1.2%) |
| Dec 2007 | -$71.54 M(+6.1%) | -$71.54 M(+1.1%) |
| Sept 2007 | - | -$70.74 M(+1.1%) |
| June 2007 | - | -$69.96 M(+1.3%) |
| Mar 2007 | - | -$69.06 M(+2.4%) |
| Dec 2006 | -$67.43 M | -$67.43 M(+1.8%) |
| Sept 2006 | - | -$66.23 M(+1.6%) |
| June 2006 | - | -$65.19 M(>+9900.0%) |
| Feb 2006 | - | -$199.00 K(+5.7%) |
| Nov 2005 | - | -$188.20 K(+4.8%) |
| Aug 2005 | - | -$179.50 K |
FAQ
- What is Cytosorbents annual retained earnings?
- What is the all time high annual retained earnings for Cytosorbents?
- What is Cytosorbents annual retained earnings year-on-year change?
- What is Cytosorbents quarterly retained earnings?
- What is the all time high quarterly retained earnings for Cytosorbents?
- What is Cytosorbents quarterly retained earnings year-on-year change?
What is Cytosorbents annual retained earnings?
The current annual retained earnings of CTSO is -$282.51 M
What is the all time high annual retained earnings for Cytosorbents?
Cytosorbents all-time high annual retained earnings is -$67.43 M
What is Cytosorbents annual retained earnings year-on-year change?
Over the past year, CTSO annual retained earnings has changed by -$28.51 M (-11.22%)
What is Cytosorbents quarterly retained earnings?
The current quarterly retained earnings of CTSO is -$295.34 M
What is the all time high quarterly retained earnings for Cytosorbents?
Cytosorbents all-time high quarterly retained earnings is -$179.50 K
What is Cytosorbents quarterly retained earnings year-on-year change?
Over the past year, CTSO quarterly retained earnings has changed by -$18.67 M (-6.75%)